11-64593548-C-T
Variant summary
Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PP2PP3_ModeratePP5_Very_Strong
The NM_144585.4(SLC22A12):c.650C>T(p.Thr217Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000198 in 1,614,066 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T217R) has been classified as Uncertain significance.
Frequency
Consequence
NM_144585.4 missense
Scores
Clinical Significance
Conservation
Publications
- hypouricemia, renal 1Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- hereditary renal hypouricemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 11 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_144585.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SLC22A12 | NM_144585.4 | MANE Select | c.650C>T | p.Thr217Met | missense | Exon 3 of 10 | NP_653186.2 | ||
| SLC22A12 | NM_001276326.2 | c.560-87C>T | intron | N/A | NP_001263255.1 | ||||
| SLC22A12 | NM_001276327.2 | c.506+666C>T | intron | N/A | NP_001263256.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SLC22A12 | ENST00000377574.6 | TSL:1 MANE Select | c.650C>T | p.Thr217Met | missense | Exon 3 of 10 | ENSP00000366797.1 | ||
| SLC22A12 | ENST00000336464.7 | TSL:1 | c.560-87C>T | intron | N/A | ENSP00000336836.7 | |||
| SLC22A12 | ENST00000377572.5 | TSL:1 | c.506+666C>T | intron | N/A | ENSP00000366795.1 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152274Hom.: 0 Cov.: 34 show subpopulations
GnomAD2 exomes AF: 0.0000478 AC: 12AN: 251216 AF XY: 0.0000515 show subpopulations
GnomAD4 exome AF: 0.0000178 AC: 26AN: 1461792Hom.: 0 Cov.: 33 AF XY: 0.0000206 AC XY: 15AN XY: 727200 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152274Hom.: 0 Cov.: 34 AF XY: 0.0000269 AC XY: 2AN XY: 74400 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Dalmatian hypouricemia Pathogenic:2
not provided Pathogenic:1
This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 217 of the SLC22A12 protein (p.Thr217Met). This variant is present in population databases (rs121907893, gnomAD 0.05%). This missense change has been observed in individual(s) with clinical features of hypouricemia (PMID: 12024214, 14694169, 23043931, 31591475). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 3513). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects SLC22A12 function (PMID: 12024214). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at